Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

IQVIA HOLDINGS INC.

(IQV)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

IQVIA : Stifel Adjusts IQVIA Holdings' Price Target to $300 From $280, Reiterates Buy Rating

07/28/2021 | 11:49am EDT


ę MT Newswires 2021
All news about IQVIA HOLDINGS INC.
10/25IQVIA : Barclays Adjusts IQVIA Holdings' Price Target to $287 from $285, Keeps Overweight ..
MT
10/22IQVIA : Morgan Stanley Adjusts Price Target on IQVIA Holdings to $290 from $280, Keeps Ove..
MT
10/22IQVIA : Management's Discussion and Analysis of Financial Condition and Results of Operati..
AQ
10/21IQVIA : Q3 2021 IQVIA Earnings Conference Call Presentation
PU
10/21Health Care Stocks Steady Pre-Bell Thursday
MT
10/21IQVIA : Q3 Adjusted Earnings, Revenue Rise; Issues Q4 Outlook; Raises Full-Year 2021 Guida..
MT
10/21IQVIA : Q3 Earnings Snapshot
AQ
10/21IQVIA : Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance - Form 8-K
PU
10/21IQVIA HOLDINGS INC. : Results of Operations and Financial Condition (form 8-K)
AQ
10/21IQVIA : Reports Third-Quarter 2021 Results and Raises Full-Year 2021 Guidance
BU
More news
Analyst Recommendations on IQVIA HOLDINGS INC.
More recommendations
Financials (USD)
Sales 2021 13 830 M - -
Net income 2021 921 M - -
Net Debt 2021 10 612 M - -
P/E ratio 2021 54,2x
Yield 2021 -
Capitalization 48 923 M 48 923 M -
EV / Sales 2021 4,30x
EV / Sales 2022 3,92x
Nbr of Employees 77 000
Free-Float 74,2%
Chart IQVIA HOLDINGS INC.
Duration : Period :
IQVIA Holdings Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends IQVIA HOLDINGS INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 18
Last Close Price 256,09 $
Average target price 288,88 $
Spread / Average Target 12,8%
EPS Revisions
Managers and Directors
Ari Bousbib Chairman, President & Chief Executive Officer
Ronald Earl Bruehlman Chief Financial Officer & Executive Vice President
Karl Guenault Chief Information Officer & Senior Vice President
W. Richard Staub President-Research & Development Solutions
Kevin C. Knightly President-Technology & Commercial Solutions
Sector and Competitors
1st jan.Capi. (M$)
IQVIA HOLDINGS INC.42.93%48 923
MODERNA, INC.230.95%139 557
LONZA GROUP AG32.63%60 898
SEAGEN INC.1.46%32 330
CELLTRION, INC.-38.02%26 036
ALNYLAM PHARMACEUTICALS, INC.52.12%23 497